1.00Open1.00Pre Close0 Volume35 Open Interest5.00Strike Price0.00Turnover170.77%IV13.23%PremiumJan 17, 2025Expiry Date0.39Intrinsic Value100Multiplier13DDays to Expiry0.61Extrinsic Value100Contract SizeAmericanOptions Type-0.5344Delta0.2676Gamma5.59Leverage Ratio-0.0228Theta-0.0011Rho-2.99Eff Leverage0.0035Vega
Alto Neuroscience Stock Discussion
Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology
Wednesday, 11th December at 8:03 am
– Data generated from Alto's precision psychiatry platform and clinical-stage product candidates highlighted across three poster presentations and a panel discussion –
– New preclinical data from a reverse translation study demonstrates the link between the mechanism of ALTO-300 and the EEG biomarker used for...
<- Blackrock ->
$Alto Neuroscience (ANRO.US)$
sec.gov/Archive...
#myANROanalysis
Larger Image: tradingview.com...
$Alto Neuroscience (ANRO.US)$
No comment yet